2024, Number 2
<< Back Next >>
Dermatología Cosmética, Médica y Quirúrgica 2024; 22 (2)
Cutaneous coccidioidomycosis. A review of reported cases in Mexico
Abac-Hernández EF, González-Martínez LY, Vázquez-Peña DY, Núñez-Jiménez LA, Cortés-López PN, Arenas R
Language: Spanish
References: 38
Page: 182-188
PDF size: 167.38 Kb.
ABSTRACT
Background: coccidioidomycosis is a systemic mycosis caused
by Coccidioides species, a dimorphic fungus, with two recognized
species as causal agents:
C. immitis y
C. posadasii. Primary cutaneous
infections are uncommon and are acquired by direct inoculation
of the fungus.
Objective: to analyze the cases or series of cases of primary
cutaneous coccidioidomycosis in Mexican patients, and provide
demographic data, clinical information, diagnosis and treatment
methods.
Methodology: four databases, PubMed, Scientific Electronic Library
Online (scielo), Scopus and Google Scholar were searched
for case reports, observational studies, and clinical trials from
January 1993 to June 2022.
Results: of the 10 case report articles, 38 patients were considered
who met the inclusion criteria, of which 73.68% were men
and 26.32% women. The three states with the highest number
of cases were Sinaloa (47.3%), Baja California (21%) and Nuevo
León (15.7%). The predominant skin lesion was the ulceration
in 39.47%, nodule in 28.95% and verrucous lesions in 28.95%;
the most common topography was the lower extremities and
head. The most frequently used diagnostic methods were culture
42.1% and direct examination 26.5%, which identified
C. immitis
and
C. posadasii. Itraconazole was used in 89.47% of cases.
Conclusions: Primary cutaneous coccidioidomycosis was found
mainly in the state of Sinaloa with ulcers, nodules and verrucous
lesions in the lower limbs. The most used diagnostic method to
identify mycosis was culture. The main treatment was itraconazole.
REFERENCES
Kirkland TN, Stevens DA, Hung C-Y et al., Coccidioides species:a review of basic research, J Fungi 2022; 8(8):859. doi.org/10.3390/jof8080859.
Bajwa AK y Rongkavilit C, Update on coccidioidomycosis in theUnited States and beyond, Global Pediatric Health 2020; 7. doi:10.1177/2333794X20969282.
Williams SL y Chiller T, Update on the epidemiology, diagnosis,and treatment of coccidioidomycosis, J Fungi (Basilea) 2022;8(7):666. doi.org/10.3390/jof8070666.
Boro R, Iyer PC y Walczak MA, Current landscape of coccidioidomycosis,J Fungi (Basilea) 2022; 8(4):413. doi.org/10.3390/jof8040413.
Laniado R, Arathoon E, Canteros C et al., Coccidioidomycosis inLatin America, Med Mycol 2019; 46-55. doi.org/10.1093/mmy/myy037.
Crum NF, Coccidioidomycosis: a contemporary review, InfectDis Ther 2022; 11(2):713-42. doi: 10.1007/s40121-022-00606-y.
McCotter OZ, Benedict K, Engelthaler DM et al., Update on theepidemiology of coccidioidomycosis in the United States, MedMycol 2019; 57(Suppl 1): S30-40. doi: 10.1093/mmy/myy095.
Dixon DM, Coccidioides immitis as a select agent of bioterrorism,J Appl Microbiol 2001; 91(4):602-5. doi: 10.1046/j.1365-2672.2001.01496.x.
Johnson RH, Sharma R, Kuran R et al., Coccidioidomycosis:a review, J Investig Med 2021; 69(2):316-23. doi:10.1136/jim-2020-001655.
Galgiani JN, Ampel NM, Blair JE et al., Infectious Diseases Societyof America (idsa), Clinical Practice Guideline for the Treatmentof Coccidioidomycosis, Clin Infect Dis 2016; 63(6):e112-46. doi: 10.1093/cid/ciw360.
García SC, Salas JC, Flores MG et al., Coccidioidomycosis andthe skin: a comprehensive review, An Bras Dermatol 2015;90(5):610-9. doi:10.1590/abd1806-4841.20153805.
Blair JE, State-of-the-art treatment of coccidioidomycosis: skinand soft-tissue infections, Ann N Y Acad Sci 2007; 1111:411-21.doi: 10.1196/annals.1406.010.
Levan NE, Occupational aspects of coccidioidomycosis, CalifMed 1954; 80(4):294-8.
Galindo-Talamantes FJ, Valdez-García JE, Galaviz-ChaparroO et al., Coccidioidomicosis cutánea primaria y sus criteriospara clasificación, Dermatol Rev Mex 2022; 66(5):593-7. doi.org/10.24245/dermatolrevmex.v66i5.8144.
Arce M, Ramírez V, Castañeda R et al., Coccidioidomicosis cutáneaprimaria por Coccidioides posadasii, Dermatol Rev Mex2016; 60(6):520-5.
Moreno-Coutiño G, Arce-Ramírez M, Medina A et al., Coccidioidomicosiscutánea: comunicación de seis casos mexicanos,Rev Chilena Infectol 2015; 32(3):339-43. doi: 10.4067/S0716-10182015000400014.
Muñoz-Estrada VF, Verdugo-Castro PN y Muñoz-Muñoz R, Coccidioidomicosiscutánea primaria, Dermatol Rev Mex 2016;60(6):531-5.
Muñoz Estrada VF, Coccidioidomicosis cutánea primaria: presentaciónde un caso con morfología atípica, Rev Med uas2012; 3(4):141-4.
Simental-Lara F y Bonifaz A, Coccidioidomicosis en la regiónlagunera de Coahuila, México, Dermatol Rev Mex 2011;55(3):140-51.
Bonifaz A, Tirado-Sánchez A y González GM, Cutaneous coccidioidomycosiswith tissue arthroconidia, Am J Trop Med Hyg2019; 100(4):772. doi:10.4269/ajtmh.18-0700.
Gildardo JM, Leobardo VA, Nora MO et al., Primary cutaneouscoccidioidomycosis: case report and review of the literature,Int J Dermatol 2006; 45(2):121-3. doi: 10.1111/j.1365-4632.2004.02446.x.
Reyna-Rodríguez IL, Ocampo-Candiani J y Chávez-Álvarez S, Primarycutaneous coccidioidomycosis: an update, Am J Clin Dermatol2020; 21(5):681-96. doi: 10.1007/s40257-020-00525-z.
Domínguez-Cota G, Zamora-Angulo LE, Osuna-Beltrán E et al.,Coccidioidomicosis cutánea primaria. Estudio epidemiológico yclínico. Serie de 16 casos, cimel 2001; 6:49-53.
Laniado-Laborín R, Arathoon EG, Canteros C, Muñiz-Salazar Ry Rendon A, Coccidioidomycosis in Latin America, Med Mycol2019; 57:S46-55. doi: 10.1093/mmy/myy03.
Kollath DR, Miller KJ y Barker BM, The mysterious desert dwellers:Coccidioides immitis and Coccidioides posadasii, causativefungal agents of coccidioidomycosis, Virulence 2019; 10(1):222-33. doi: 10.1080/21505594.2019.1589363.
Rojas-García OC, Moreno-Treviño MG, González-Salazar F et al.,Coccidioidomicosis cutánea primaria en infante, Gac Med Mex2014; 150(2):175-6.
Tortorano AM, Carminati G, Tosoni A y Tintelnot K, Primary cutaneouscoccidioidomycosis in an Italian nun working in SouthAmerica and review of published literature, Mycopathologia2015; 180(3-4):229-35. doi: 10.1007/s11046-015-9895-0.
Drutz DJ, Huppert M, Sun SH y McGuire WL, Human sexhormones stimulate the growth and maturation of Coccidioidesimmitis, Infect Immun 1981; 32(2):897-907. doi: 10.1128/iai.32.2.897-907.1981.
Policepatil SM y Sivasubramanian G, Diagnostic delays in cutaneouscoccidioidomycosis: a report from Central California,Med Mycol 2023; 61(11):myad107. doi: 10.1093/mmy/myad107.
Crum NF, Lederman ER, Stafford CM, Parrish JS y WallaceMR, Coccidioidomycosis: a descriptive survey of a reemergingdisease. Clinical characteristics and current controversies,Medicine (Baltimore) 2004; 83(3):149-75. doi: 10.1097/01.md.0000126762.91040.fd.
Díaz JH, Travel-related risk factors for coccidioidomycosis, JTravel Med 2018; 25(1):1-8. doi: 10.1093/jtm/tay027.
DiCaudo DJ, Coccidioidomycosis: a review and update, J Am AcadDermatol 2006; 55(6):929-42. doi: 10.1016/j.jaad.2006.04.039.
Chang A, Tung RC, McGillis TS et al., Primary cutaneous coccidioidomycosis,J Am Acad Dermatol 2003; 49(5):944-9. doi:10.1016/S0190-9622(03)00462-6.
Gabe LM, Malo J y Knox KS, Diagnosis and management ofcoccidioidomycosis, Clin Chest Med 2017; 38(3):417-33. doi:10.1016/j.ccm.2017.04.005.
Stockamp NW y Thompson GR 3rd, Coccidioidomycosis, InfectDis Clin North Am 2016; 30(1):229-46. doi: 10.1016/j.idc.2015.10.008.
Catanzaro A, Fierer J y Friedman PJ, Fluconazole in the treatmentof persistent coccidioidomycosis, Chest 1990; 97(3):666-9. doi: 10.1378/chest.97.3.666.
Graybill JR, Stevens DA, Galgiani JN et al., Tratamiento con itraconazolde la coccidioidomicosis, Am J Med 1990; 89(3):282-90. doi: 10.1016/0002-9343(90)90339-f.
Reyes-Montes MR, Pérez-Huitrón MA, Ocaña-Monroy JL et al.,El hábitat de Coccidioides spp. y el papel de los animales comoreservorios y diseminadores en la naturaleza, bmc Infecta Dis2016; 16(1):550. doi: 10.1186/s12879-016-1902-7.